Balyasny Asset Management LLC Neuronetics, Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,481,771 shares of STIM stock, worth $8.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,481,771
Previous 1,144,232
29.5%
Holding current value
$8.21 Million
Previous $869,000
153.97%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding STIM
# of Institutions
48Shares Held
10MCall Options Held
24.1KPut Options Held
200-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$9.63 Million1.44% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.5MShares$8.31 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$7.1 Million0.0% of portfolio
-
Four World Capital Management LLC New York, NY858KShares$4.75 Million0.69% of portfolio
-
Parian Global Management LP Pound Ridge, NY830KShares$4.6 Million8.59% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $150M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...